期刊文献+

杂环金属配合物的合成及抑菌活性

Synthesis of Five-membered Heterocycle-Copper(Ⅱ)Complexes and Antibacterial Activity
下载PDF
导出
摘要 为寻找新型广谱的抗菌素先导化合物,以5-溴呋喃-2-羧酸和2-四氢糠酸为起始原料合成了2种五元杂环铜配合物,利用(1)^H NMR、(13)^C NMR对其结构及性质进行表征和分析,以平板菌落计数法测定铜配合物对大肠杆菌和金黄色葡萄球菌的抑制作用。初步体外抑菌活性显示,在0.038 mg/mL浓度下,目标化合物对两种细菌均具有较好的抑制活性。其中,5-(5-溴呋喃-2-基)-1,3,4-噻二唑铜(化合物4)的抑菌活性较强,其浓度与抑菌活性呈线性关系。 In order to find new broad-spectrum antibiotic lead compounds,two five-membered heterocycle-copper(Ⅱ)complexes was synthesized from 5-bromofuran-2-carboxylic acid and 2-tetrahydrofuroic acid,and their as starting materials,and their structures and properties were characterized and analyzed by(1)^H NMR and (13)^C NMR.The inhibitory effect of copper complexes on Staphylococcus aureus was determined by plate colony counting method.The preliminary in vitro antibacterial activity showed that the target compounds had good inhibitory activity against Staphylococcus aureus at the concentration of 0.038 mg/mL.Among them,5-(5-bromofuran-2-yl)-1,3,4-thiadiazole copper(compound 4)has stronger antibacterial activity,and its concentration has a linear relationship with the antibacterial activity.
作者 王文龙 Wang Wenlong(Pall Corporation,Shanghai 201210,China)
出处 《广东化工》 CAS 2022年第17期108-110,共3页 Guangdong Chemical Industry
关键词 杂环 金属配合物 铜离子 合成 抑菌活性 heterocyclic metal complex copper ions synthesis antibacterial activity
  • 相关文献

参考文献2

二级参考文献22

  • 1陈小薇,梁琼芳,洪嘉铭,李增禧.帕金森病与血清中微量元素关系的研究[J].中国医师杂志,2003,5(S1):228-229. 被引量:6
  • 2Llanos RM, Mercer JF. The molecular basis of copper homeostasis and copper - related disorders. DNA Cell Biol, 2002, 21(4): 259 -270.
  • 3Texel S J, Xu X, Harris ZL. Ceruloplasmin in neurodegenerative diseases. Biochem Soc Trans, 2008, 36 (6) : 1 277 - 1 281.
  • 4Mercer JF. The molecular basis of copper - transport diseases. Trends Mol Med, 2001, 7(2) : 64 -69.
  • 5Madsen E, Gitlin JD. Copper deficiency. Curr Opin Gastroenterol, 2007; 23 (2) : 187 - 192.
  • 6Gaggelli E, Kozlowski H, Valensin D, etal. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev, 2006, 106(6) : 1 995 -2 044.
  • 7Kumar N, Ahlskog JE, Klein C J, et al. Imaging features of copper deficiency myelopathy: a study of 25 cases. Neuroradiology, 2006, 48 (2) : 78 - 83.
  • 8Klevay LM. Alzheimer's disease as copper de? ciency. Medical Hypotheses, 2008, 70 (4) : 802 - 807.
  • 9Donnelly PS, Xiao Z, Wedd AG. Copper and Alzheimer's disease. Curr Opin Chem Biol, 2007, 11 (2) : 128 -133.
  • 10Smith DP, Smith DG, Curtain CC, et al. Copper- mediated amyloid - β toxicity is associated with an intermolecular histidine bridge. J Biol Chem, 2006, 281(22) : 15 145 -15 154.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部